Research programme: PPAR agonists - Bayer
Alternative Names: PPAR alpha/gamma/delta agonists - Bayer; PPAR gamma/delta agonists - BayerLatest Information Update: 25 Mar 2010
At a glance
- Originator Bayer
- Class
- Mechanism of Action Peroxisome proliferator-activated receptor alpha agonists; Peroxisome proliferator-activated receptor delta agonists; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Metabolic syndrome; Type 2 diabetes mellitus
Most Recent Events
- 25 Mar 2010 Discontinued - Preclinical for Metabolic syndrome in USA (PO)
- 25 Mar 2010 Discontinued - Preclinical for Type-2 diabetes mellitus in USA (PO)
- 26 Sep 2006 Preclinical trials in Metabolic syndrome in USA (PO)